SB
Sailie Bio, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$100Ksold at filing
Total offering$250K$150K still open
Investors in the raise2count reported to the SEC
FiledJul 14, 2026first sale Jun 28, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gregory Philip DracoulisExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.